Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Is prophylaxis for osteoporosis indicated after acute spinal cord injury?

Is prophylaxis for osteoporosis indicated after acute spinal cord injury?

Spinal Cord Series and Cases, 2019 · DOI: 10.1038/s41394-019-0167-y · Published: January 1, 2019

Spinal Cord InjuryMusculoskeletal Medicine

Simple Explanation

Spinal cord injury (SCI)-related osteoporosis is a common complication, particularly in individuals with tetraplegia or paraplegia, leading to bone demineralization, fractures, and decreased quality of life. The primary cause is the loss of mechanical stimuli due to paralysis, not merely immobilization. After an acute SCI, bone loss occurs rapidly, with osteoclast activity significantly increasing. This can result in hypercalciuria and hypercalcemia, potentially leading to complications if not managed promptly through early mobilization and hydration. Supplementation with Vitamin D is necessary before starting antiresorptive drug therapy. Low vitamin D levels can lead to inadequate calcium absorption, and using antiresorptive agents without addressing this can cause severe hypocalcemia.

Study Duration
Not specified
Participants
Not specified
Evidence Level
Not specified

Key Findings

  • 1
    Traumatic SCI results in various degrees of osteoporosis below the level of injury, primarily due to the loss of mechanical stimuli from paralysis.
  • 2
    Early administration of bisphosphonates after injury, along with controlling calcium metabolism and engaging in rehabilitation programs that include walking, can limit bone loss and retain bone density, especially in individuals with incomplete lesions.
  • 3
    Sclerostin levels increase after acute SCI, inhibiting bone formation, suggesting it as a potential target for preventing bone loss; however, anti-sclerostin antibody treatment may be ineffective in chronic SCI.

Research Summary

SCI-related osteoporosis is a common complication that leads to bone demineralization and fractures, reducing the quality of life. The loss of mechanical stimuli due to paralysis is the primary cause of SCI-related bone loss. Antiresorptive therapy combined with rehabilitation programs limits bone loss and retains bone density, especially for incomplete lesions.

Practical Implications

Early Intervention

Prompt administration of bisphosphonates and monitoring of calcium metabolism are crucial in managing acute SCI-related bone loss.

Rehabilitation Programs

Incorporating walking and other weight-bearing exercises in rehabilitation can promote bone formation and density.

Vitamin D Supplementation

Ensuring adequate vitamin D levels is essential before initiating antiresorptive therapies to prevent hypocalcemia.

Study Limitations

  • 1
    Small numbers of subjects in studies
  • 2
    Heterogeneity of level of injury and AIS scale
  • 3
    Variations in drug interventions and outcomes

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury